in News
DARPA Taps Sorrento for COVID-19 Rapid Countermeasure Effort
A subsidiary of Sorrento Therapeutics has landed a potential $34M contract from the Defense Advanced Research Projects Agency to produce a rapid countermeasure against COVID-19.
Processing....
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website.
Accept